Company
D.N.A Biomedical Solutions Ltd
Headquarters: Petah Tikva, Israel
CEO: Mr. Yonatan Malcha
Market Cap
₪88.7 Million
ILS as of Jan. 1, 2024
US$24.5 Million
D.N.A Biomedical Solutions Ltd Categories
Israel Healthcare BiotechnologyIsrael Healthcare Israel Biotechnology
Top Competitors by Market Capitalization
Industry: Biotechnology
| Company | Market Cap (USD) |
|---|---|
| Novo Nordisk | $461.52 B |
| Vertex Pharmaceuticals Incorporated | $107.23 B |
| Regeneron Pharmaceuticals, Inc. | $100.01 B |
| CSL Limited | $94.74 B |
| Marinomed Biotech AG | $73.23 B |
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $586.39 B |
| UnitedHealth Group | $504.47 B |
| Novo Nordisk | $461.52 B |
| Johnson & Johnson | $387.50 B |
| Merck | $296.51 B |
Detailed Description
D.N.A Biomedical Solutions Ltd. develops and commercializes laser spectrometry-based trace detection systems in Israel. The company offers hybrid detection kits, vehicles scanning systems, handheld laser detectors, laser scanner stations, trace detectors, handheld IMS detectors, remote laser scanners, drug detection kits, and tactical lie detector products. It serves transportation, seaport security, customs, airports security, mega events, infrastructure protection, check point and borders, and law enforcement applications. The company was formerly known as Laser Detect Systems Ltd. D.N.A Biomedical Solutions Ltd. was founded in 2004 and is headquartered in Petah Tikva, Israel.
Top 1-year algo backtest: +269.94%
$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Stocks & Indices
D.N.A Biomedical Solutions Ltd has the following listings and related stock indices.
Stock: TASE: DNA wb_incandescent